These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 29545331)

  • 1. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
    Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
    Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dicer reprograms stromal fibroblasts to a pro-inflammatory and tumor-promoting phenotype in ovarian cancer.
    Yang Z; Jin P; Xu S; Zhang T; Yang X; Li X; Wei X; Sun C; Chen G; Ma D; Gao Q
    Cancer Lett; 2018 Feb; 415():20-29. PubMed ID: 29199004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemosensitizing effects of metformin on cisplatin- and paclitaxel-resistant ovarian cancer cell lines.
    Dos Santos Guimarães I; Ladislau-Magescky T; Tessarollo NG; Dos Santos DZ; Gimba ERP; Sternberg C; Silva IV; Rangel LBA
    Pharmacol Rep; 2018 Jun; 70(3):409-417. PubMed ID: 29627688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomal transfer of stroma-derived miR21 confers paclitaxel resistance in ovarian cancer cells through targeting APAF1.
    Au Yeung CL; Co NN; Tsuruga T; Yeung TL; Kwan SY; Leung CS; Li Y; Lu ES; Kwan K; Wong KK; Schmandt R; Lu KH; Mok SC
    Nat Commun; 2016 Mar; 7():11150. PubMed ID: 27021436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-1β promotes ovarian tumorigenesis through a p53/NF-κB-mediated inflammatory response in stromal fibroblasts.
    Schauer IG; Zhang J; Xing Z; Guo X; Mercado-Uribe I; Sood AK; Huang P; Liu J
    Neoplasia; 2013 Apr; 15(4):409-20. PubMed ID: 23555186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the IGF signaling pathway reverses cisplatin resistance in ovarian cancer cells.
    Du J; Shi HR; Ren F; Wang JL; Wu QH; Li X; Zhang RT
    BMC Cancer; 2017 Dec; 17(1):851. PubMed ID: 29241458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
    Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
    Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment.
    Yeung TL; Leung CS; Li F; Wong SS; Mok SC
    Biomolecules; 2016 Jan; 6(1):3. PubMed ID: 26751490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The oncogenic Golgi phosphoprotein 3 like overexpression is associated with cisplatin resistance in ovarian carcinoma and activating the NF-κB signaling pathway.
    He S; Niu G; Shang J; Deng Y; Wan Z; Zhang C; You Z; Shen H
    J Exp Clin Cancer Res; 2017 Oct; 36(1):137. PubMed ID: 28978336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesothelial Cell HIF1α Expression Is Metabolically Downregulated by Metformin to Prevent Oncogenic Tumor-Stromal Crosstalk.
    Hart PC; Kenny HA; Grassl N; Watters KM; Litchfield LM; Coscia F; Blaženović I; Ploetzky L; Fiehn O; Mann M; Lengyel E; Romero IL
    Cell Rep; 2019 Dec; 29(12):4086-4098.e6. PubMed ID: 31851935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Losartan treatment enhances chemotherapy efficacy and reduces ascites in ovarian cancer models by normalizing the tumor stroma.
    Zhao Y; Cao J; Melamed A; Worley M; Gockley A; Jones D; Nia HT; Zhang Y; Stylianopoulos T; Kumar AS; Mpekris F; Datta M; Sun Y; Wu L; Gao X; Yeku O; Del Carmen MG; Spriggs DR; Jain RK; Xu L
    Proc Natl Acad Sci U S A; 2019 Feb; 116(6):2210-2219. PubMed ID: 30659155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metabolic cross-talk between epithelial cancer cells and stromal fibroblasts in ovarian cancer progression: Autophagy plays a role.
    Thuwajit C; Ferraresi A; Titone R; Thuwajit P; Isidoro C
    Med Res Rev; 2018 Jul; 38(4):1235-1254. PubMed ID: 28926101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term treatment of metformin impedes development of chemoresistance by regulating cancer stem cell differentiation through taurine generation in ovarian cancer cells.
    Bishnu A; Sakpal A; Ghosh N; Choudhury P; Chaudhury K; Ray P
    Int J Biochem Cell Biol; 2019 Feb; 107():116-127. PubMed ID: 30593952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukotriene B4 receptor-2 contributes to chemoresistance of SK-OV-3 ovarian cancer cells through activation of signal transducer and activator of transcription-3-linked cascade.
    Park J; Park SY; Kim JH
    Biochim Biophys Acta; 2016 Feb; 1863(2):236-43. PubMed ID: 26597704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer microenvironment: implications for cancer dissemination and chemoresistance acquisition.
    Thibault B; Castells M; Delord JP; Couderc B
    Cancer Metastasis Rev; 2014 Mar; 33(1):17-39. PubMed ID: 24357056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic Identification of Druggable Epithelial-Stromal Crosstalk Signaling Networks in Ovarian Cancer.
    Yeung TL; Sheng J; Leung CS; Li F; Kim J; Ho SY; Matzuk MM; Lu KH; Wong STC; Mok SC
    J Natl Cancer Inst; 2019 Mar; 111(3):272-282. PubMed ID: 29860390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knockdown of Eag1 Expression by RNA Interference Increases Chemosensitivity to Cisplatin in Ovarian Cancer Cells.
    Hui C; Lan Z; Yue-li L; Li-lin H; Li-lin H
    Reprod Sci; 2015 Dec; 22(12):1618-26. PubMed ID: 26079730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
    Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
    PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microenvironment remodeled by tumor and stromal cells elevates fibroblast-derived COL1A1 and facilitates ovarian cancer metastasis.
    Li M; Wang J; Wang C; Xia L; Xu J; Xie X; Lu W
    Exp Cell Res; 2020 Sep; 394(1):112153. PubMed ID: 32589888
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reprogramming of stromal fibroblasts by SNAI2 contributes to tumor desmoplasia and ovarian cancer progression.
    Yang Z; Yang X; Xu S; Jin P; Li X; Wei X; Liu D; Huang K; Long S; Wang Y; Sun C; Chen G; Hu J; Meng L; Ma D; Gao Q
    Mol Cancer; 2017 Oct; 16(1):163. PubMed ID: 29041931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.